Tests a mindfulness eating program for teens with obesity
Tests a mindfulness-based eating program against education in teens with obesity.
Plain-language title generated from the registry record
Registry title: EAT SMART Teen Study
Key facts
- Where
- Ottawa, CanadaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 12 and 17 years old?
Source: NCT07130838, who can take part
Where in Canada
- Children'S Hospital Of Eastern OntarioOttawa, CanadaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Gary Goldfield
- Trial code
- NCT07130838
- Record updated
- 20 October 2026
- Original description
The goal of this controlled trial is to assess the feasability and efficacy of a 12-week mindfulness-based intervention (MBI) in adolescents living with obesity. The study will include youth ages 12 to 17 who are waitlisted at the Centre for Healthy Active Living (CHAL) at the Children's Hospital of Eastern Ontario (CHEO).Read full original descriptionShow less
Effects of Application-based Eating Awareness Training on Disordered Eating in Youth With Obesity: The EAT SMART Teen Study
The goal of this controlled trial is to assess the feasability and efficacy of a 12-week mindfulness-based intervention (MBI) in adolescents living with obesity. The study will include youth ages 12 to 17 who are waitlisted at the Centre for Healthy Active Living (CHAL) at the Children's Hospital of Eastern Ontario (CHEO).
We hypothesize that the MB-EAT Teen intervention will demonstrate good feasibility and usability among adolescents living with obesity. We also expect that, compared with the EAT SMART Teen psychoeducation program, MB-EAT Teen may lead to greater improvements in disordered eating behaviours, food-related self-regulation, mindfulness, emotional well-being, body image, and health-related quality of life.
Inclusion: Have access to a mobile/tablet device with internet access; Are aged 12-17 years; Are waitlisted or have recently been waitlisted for treatment at CHAL at CHEO; Must sign and date the informed consent form, or provide assent and have a Substitute Decision Maker (SDM) provide informed consent; Have the ability to complete the study in English.
Exclusion: Have previously been diagnosed with Bulimia Nervosa, purging subtype; Have previously been diagnosed with a condition that may impair their participation (e.g. cognition and/or neurodevelopment, particularly Fetal Alcohol Syndrome, Autism Spectrum Disorder (ASD), Down Syndrome, Prader- Willi Syndrome, Fragile X Syndrome); Have previously been diagnosed with a neurodevelopmental disorder (e.g., ADHD) and symptoms are not controlled by medication; Are currently enrolled in a weight management program; Have been diagnosed with a concussion in the past 6-months.